LEXINGTON, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a pacesetter within the fast detection of sepsis-causing pathogens and antibiotic resistance genes, introduced at this time that it’ll report monetary outcomes for the third quarter 2022 after market shut on Thursday, November 10, 2022. Company administration will host a corresponding convention name starting at 4:30 p.m. Eastern Time.
Investors excited about listening to the convention name could achieve this by accessing a dwell and archived webcast of the occasion at www.t2biosystems.com, on the Investors web page within the Events & Presentations part.
About T2 Biosystems:
T2 Biosystems, a pacesetter within the fast detection of sepsis-causing pathogens and antibiotic resistance genes, is devoted to enhancing affected person care and decreasing the price of care by serving to clinicians successfully deal with sufferers quicker than ever earlier than. T2 Biosystems’ merchandise embrace the T2Dx® Instrument, T2Bacteria® Panel, T2Candida® Panel, T2Resistance® Panel, and T2SARS-CoV-2™ Panel and are powered by the Company’s proprietary T2 Magnetic Resonance (T2MR®) know-how. T2 Biosystems has an energetic pipeline of future merchandise, together with the T2Biothreat Panel, T2Cauris™ Panel, T2Lyme™ Panel, in addition to extra merchandise for the detection of bacterial and fungal pathogens and related antimicrobial resistance markers. For extra info, please go to www.t2biosystems.com.
Investor Contact:
Philip Trip Taylor, Gilmartin Group
[email protected]
415-937-5406
